Prospectus Supplement No. 2 to FCX prospectus dated 4/30/02  (F5014220.DOC;1)


Filed pursuant to Rule 424(b)(3)

Registration No. 333-104564


Prospectus Supplement No. 2 to Prospectus


Freeport-McMoRan Copper & Gold Inc.


$575,000,000


7% Convertible Senior Notes Due 2011 and the

Common Stock Issuable Upon Conversion of the

7% Convertible Senior Notes Due 2011


____________________


This prospectus supplement relates to the resale by the selling securityholders listed below of 7% Convertible Senior Notes due 2011 of Freeport-McMoRan Copper & Gold Inc., and the shares of class B common stock of Freeport-McMoRan Copper & Gold Inc. issuable upon the conversion of the notes. You should read this prospectus supplement together with the prospectus dated April 30, 2003, and the prospectus supplement No. 1 dated May 15, 2003, which are to be delivered with this prospectus supplement.

The table below (1) sets forth additional and updated information with respect to the principal amount of notes owned by each selling securityholder, and the shares of common stock into which such notes are convertible, that may be offered under the prospectus and the prospectus supplements by the selling securityholders, and (2) supplements and, to the extent inconsistent with, amends both the table appearing in the section entitled “Selling Securityholders” beginning on page 33 of the prospectus and the table set forth in prospectus supplement No. 1. To the extent a selling securityholder is listed both in the table below and in either or both the table appearing in the prospectus and the table appearing in prospectus supplement No. 1, the information set forth below regarding that selling securityholder supercedes the information set forth in the prospectus and prospectus supplement No. 1.

The number of shares of our class B common stock shown in the table below assumes conversion of the full amount of notes held by such holder at the initial conversion rate of 32.3918 shares of class B common stock per $1,000 principal amount of notes.  This conversion rate is subject to certain adjustments as described under “Description of Notes – Conversion Rights” in the prospectus.  Accordingly, the shares of class B common stock issuable upon conversion of the notes may increase or decrease from time to time.  Under the terms of the indenture, fractional shares will not be issued upon conversion of the notes.  Cash will be paid in lieu of fractional shares, if any.  As of April 30, 2003, we had 145,485,848 shares of our class B common stock outstanding.

The information in the table below is based on information provided by or on behalf of the selling securityholders. The selling securityholders identified below may have sold, transferred or otherwise disposed of all or a portion of their notes or class B common stock since the date on which they provided the information regarding their notes or class B common stock in transactions exempt from the registration requirements of the Securities Act of 1933.  Because the selling securityholders may offer all or some portion of the notes or the class B common stock to be offered by them, we cannot estimate the amount of any sales.






Name of Selling Securityholder

Principal
Amount of Notes
Owned and
Offered

Percentage of
Notes
Outstanding**

Number of Shares
of Common Stock
That May Be Sold

    

Bear Stearns & Co., Inc.

1,000,000

*  

32,391

BNP Paribas Arbitrage

9,500,000

1.65%

307,722

GLG Global Convertible Fund

3,950,000

*  

127,947

GLG Global Convertible UUTS Fund

1,050,000

*  

34,011

GLG Market Neutral Fund

24,000,000

4.17%

777,403

North Pole Capital Master Fund

1,210,000

*  

39,194

Polar Hedge Enhanced Income Trust

40,000

*  

1,295

S.A.C. Capital Associates, LLC

7,000,000

1.22%

226,742

Topanga XI

4,000,000

*  

129,567

UBS Warburg LLC

1,950,000

*  

63,164


__________


*

Less than 1%

**

Based on total notes in the principal amount of $575,000,000 outstanding.


____________________


Investing in the notes involves significant risks that are described in the "Risk Factors" section beginning on page 5 of the prospectus.

____________________


Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved these securities or passed on the adequacy or accuracy of this prospectus.  Any representation to the contrary is a criminal offense.

____________________


The date of this Prospectus Supplement is May 29, 2003.